Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · Real-Time Price · USD

1.355

-0.055 (-3.90%)

At close: May 11, 2026, 4:00 PM EDT

1.350

-0.005 (-0.37%)

Pre-market: May 12, 2026, 6:13 AM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Integrated Platform for Genetic Analysis	160.01M	154.01M	200.52M	128.30M	130.51M
Integrated Platform for Genetic Analysis Growth	3.89%	-23.19%	56.29%	-1.69%	65.43%
Total	160.01M	154.01M	200.52M	128.30M	130.51M
Total Growth	3.89%	-23.19%	56.29%	-1.69%	65.43%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Americas	-	-	-	-	64.52M
Americas Growth	-	-	-	-	73.09%
Europe, Middle East and Africa	44.05M	34.59M	40.66M	22.60M	30.27M
Europe, Middle East and Africa Growth	27.34%	-14.91%	79.92%	-25.35%	58.78%
Asia Pacific	43.16M	40.71M	54.45M	36.15M	35.72M
Asia Pacific Growth	6.01%	-25.24%	50.65%	1.19%	58.40%
United States of America	69.70M	75.30M	100.50M	66.80M	-
United States of America Growth	-7.44%	-25.07%	50.45%	-	-
Americas (excl. United States)	3.10M	3.41M	4.91M	2.76M	-
Americas (excl. United States) Growth	-9.18%	-30.53%	77.83%	-	-
Total	160.01M	154.01M	200.52M	128.30M	130.51M
Total Growth	3.89%	-23.19%	56.29%	-1.69%	65.43%

Source: S&P Global Market Intelligence.